(Q28376754)

2

0 references

W C Moore

3

0 references

P Wisniewski

4

0 references

J R Hebel

5

0 references

C Lanni

6

0 references

L M Dubé

7

0 references

E R Bleecker

American Journal of Respiratory and Critical Care Medicine

8

0 references

language of work or name

English

0 references

publication date

April 2000

0 references

published in

0 references

volume

161

0 references

issue

4 Pt 1

0 references

page(s)

1229-36

0 references

cites work

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Human alveolar macrophages produce leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026

Cytokines in symptomatic asthma airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9904026